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1 Glossary of Terms: Vision Screening 
Abnormal test result ƚĞƐƚƌĞƐƵůƚǁŚĞƌĞĂŶŽƌŵĂů ?ƉĂƐƐ ?ƌĞƐƉŽŶƐĞĐŽƵůĚŶŽƚďĞ
detected under good conditions. The result on screening 
ĞƋƵŝƉŵĞŶƚŵĂǇŝŶĚŝĐĂƚĞ ?ŶŽƌĞƐƉŽŶƐĞ ? ? ?ĨĂŝů ? ?Žƌ ?ƌĞĨĞƌ  ? 
Attendance rate The proportion of all those invited for screening that are tested 
and receive a result: 
 
x Invited for screening includes all those that are offered 
the screening test. 
x dĞƐƚĞĚĂŶĚƌĞĐĞŝǀĞĂƌĞƐƵůƚĐŽƵůĚďĞĂ ?ƉĂƐƐ ?Žƌ ?ƌĞĨĞƌƌĂů
ƚŽĚŝĂŐŶŽƐƚŝĐĂƐƐĞƐƐŵĞŶƚ ? ?
 
Attendance rate provides information on the willingness of 
families to participate in screening. 
Compliance with 
referral (percentage) 
The percentage of those who are referred from screening to a 
diagnostic assessment that actually attend the diagnostic 
assessment. 
 
Percentage of compliance provides information on the 
willingness of families to attend the diagnostic assessment after 
referral from screening. 
Coverage The proportion of those eligible for screening that are tested and 
receive a result: 
 
x Eligible for screening includes those within the population 
that are covered under the screening or health care 
programme. 
x dĞƐƚĞĚĂŶĚƌĞĐĞŝǀĞĂƌĞƐƵůƚĐŽƵůĚďĞĂ ?ƉĂƐƐ ?Žƌ ?ƌĞĨĞƌƚŽ
ĚŝĂŐŶŽƐƚŝĐĂƐƐĞƐƐŵĞŶƚ ? ? 
 
Factors such as being offered screening, willingness to 
participate, missed screening, ability to complete the screen, and 
ability to document the screening results will influence the 
coverage. 
False negatives The percentage of children with a visual deficit (defined by the 
ƚĂƌŐĞƚĐŽŶĚŝƚŝŽŶ ?ƚŚĂƚƌĞĐĞŝǀĞĂƌĞƐƵůƚŽĨ ?ƉĂƐƐ ?ĚƵƌŝŶŐƐĐƌĞĞŶŝŶŐ ? 
 
Example: If 100 children with visual deficit are screened, and 1 
child passes the screening, the percentage of false negatives is 
1%. 
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False positives The percentage of children with normal vision that are referred 
from screening to a diagnostic assessment. 
Guidelines Recommendations or instructions provided by an authoritative 
body on the practice of screening in the country or region. 
Vision screening 
professional 
A person qualified to perform vision screening, according to the 
practice in the country or region. 
Inconclusive test 
result 
ƚĞƐƚƌĞƐƵůƚǁŚĞƌĞĂŶŽƌŵĂů ?ƉĂƐƐ ?ƌĞƐƉŽŶƐĞĐŽƵůĚŶŽƚďĞ
detected due to poor test conditions or poor cooperation of the 
child.  
Invited for screening Infants/children and their families who are offered screening. 
Outcome of vision 
screening 
An indication of the effectiveness or performance of screening, 
such as a measurement of coverage rate, referral rate, number of 
children detected, etc. 
Untreated amblyopia Those children who have not received treatment for amblyopia 
due to missed screening or missed follow-up appointment. 
Persistent amblyopia Amblyopia that is missed by screening, or present after the child 
has received treatment. 
Positive predictive 
value 
The percentage of children referred from screening who have a 
confirmed vision loss. 
 
For example, if 100 babies are referred from screening for 
diagnostic assessment and 10 have normal vision and 90 have a 
confirmed visual defect, the positive predictive value would be 
90%. 
Prevalence The percentage or number of individuals with a specific disease 
or condition. Prevalence can either be expressed as a percentage 
or as a number out of 1000 individuals within the same 
demographic. 
Programme An organised system for screening, which could be based 
nationally, regionally or locally. 
Protocol Documented procedure or sequence for screening, which could 
include which tests are performed, when tests are performed, 
procedures for passing and referring, and so forth. 
Quality assurance A method for checking and ensuring that screening is functioning 
adequately and meeting set goals and benchmarks. 
Referral criteria A pre-determined cut-off boundary for when a child should be 
re-tested or seen for a diagnostic assessment.  
Risk babies / Babies 
at-risk 
All infants that are considered to be at-risk or have risk-factors 
for vision defects/ophthalmic pathology according to the 
screening programme. 
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Two common risk factors are admission to the neonatal-intensive 
care unit (NICU) or born prematurely. However, other risk factors 
for visual defects may also be indicated in the screening 
programme. 
Sensitivity The percentage of children with visual defects that are identified 
via the screening programme. 
 
For example, if 100 babies with visual defects are tested, and 98 
of these babies are referred for diagnostic assessment and 2 pass 
the screening, the sensitivity is 98%. 
Specificity The percentage of children with normal vision that pass the 
screening. 
 
For example, if 100 babies with normal vision are tested, and 10 
of these babies are referred for diagnostic assessment and 90 
pass the screening, the specificity is 90%. 
Target condition The visual defect you are aiming to detect via the screening 
programme. 
Well, healthy babies Infants who are not admitted into the NICU or born prematurely 
(born after a gestation period of less than 37 weeks).  
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2 Abbreviations 
ACT  Alternating Cover Test 
AR  Autorefraction 
AS  Automated Screening 
CT  Cover Test 
CV  Colour Vision 
EI Eye Inspection 
EM  Eye Motility 
Fix  Fixation 
GDP  Gross Domestic Product 
GP General Practitioner 
Hir  Hirschberg test 
NICU Neonatal-intensive care unit 
PM Pursuit Movements 
PPP  Purchasing Power Parity 
PR  Pupillary Reflexes 
RE  Retinal Examination 
ROP Retinopathy of Prematurity 
RR  Red Reflex Testing 
SV  Stereopsis 
VA  Visual Acuity  
WHO  World Health Organisation 
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3 Population and Healthcare Overview 
The population of Greece is 10,760,421 (World Bank, 2018a) and a birth rate estimated at 
8.6 births/1,000 population in 2016 (World Bank, 2018b). The change in population and birth 
rate from 1960 to 2017 is shown in Figure 1, graphs A and B respectively. 
Greece has a reported population density of 84 people per square kilometre in 2017 and this 
has risen from 65 people per square kilometre in 1961 (World Bank, 2018c). Infant mortality 
in 2017 is estimated at 4.3 deaths/1,000 live births in total (World Bank, 2018d). 
The average life expectancy in Greece is estimated at 81 years (World Bank, 2018e), with a 
death rate of 11 deaths/1,000 population in 2016 (World Bank, 2018f). Greece has a gross 
national income per capita (PPP int. $, 2013) of $25,000 (WHO, 2016). The estimated total 
expenditure on health per capita in 2014) was $2,098 (Intl $) and the total expenditure on 
health in 2014 as percentage of GDP was 8.1% (WHO, 2016).
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Figure 1: Change in the Total Population and Birth Rate in Greece between 1960 and 2017 
 
Source: Information sourced from World Bank (2018) 
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4 Vision Screening Commissioning and Guidance 
Vision screening in Greece is organised nationally, however, there is no specific programme, 
only guidelines that have been available since 2015. These guidelines were released by the 
Institute of Child Health, but were only accepted as national guidelines in 2018. Vision 
screening is not embedded into a general preventative child healthcare screening system. 
There are no regional differences. To date (October 2018) there have been no revisions of the 
guidelines.  
Vision screening is free in public hospitals and primary care units, however, parents can opt 
to pay for screening in private practices. Vision screening is delivered by ophthalmologists, 
some paediatricians and general practitioners (GP) in public hospitals, primary care units and 
private practices. It is not known how many vision screening professionals there are per 
million population, but there are many more paediatricians and GPs that could perform vision 
screening. Nurses in primary care, practice assistants and nursery teachers have been 
identified as professionals that who do not currently screen, but could do so with additional 
training. Currently, there is no specific training for vision screeners available. There are no 
methods for quality monitoring imposed by the government and there has been no research 
carried out concerning vision screening in Greece.  
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5 Screening programme  
The target conditions screened for are retinopathy of prematurity, congenital eye disorders, 
reduced visual acuity and amblyopia. The health care professionals delivering vision 
screening, venue for screening and tests used vary depending on the age of the child. Specific 
details of the screening offered within each age group are described more fully in sections 5.1 
to 5.4 below. 
5.1 Vision screening - Preterm babies 
Preterm babies up to the age of 3 months are screened by an ophthalmologist in either a 
hospital or a private clinic. The tests conducted at this age include eye inspection, fixation, 
red reflex testing, eye motility, Hirschberg test, retinal examination, pursuit movements and 
pupillary reflexes. 
5.2 Vision screening - Birth to 3 months 
Well, healthy babies up to the age of 3 months are screened by either a paediatrician or an 
ophthalmologist in a child healthcare centre, primary care unit or private clinic. Babies are 
screened three times: at birth, at 1 to 2 weeks and at 2 months of age. Parents choose the 
paediatrician or venue. The tests conducted at this age include eye inspection, fixation, red 
reflex testing, eye motility, Hirschberg test, retinal examination, pursuit movements and 
pupillary reflexes. Babies are referred for further diagnostic examination after one abnormal 
test result. Decisions about repeat screening or referral for diagnostic testing in those with 
inconclusive results or poor cooperation is at the discretion of the doctor.  
5.3 Vision screening - 3 months to 36 months 
Children aged 3 to 36 months are screened by either a paediatrician or an ophthalmologist in 
hospital, private clinic or primary care unit. Parents choose the paediatrician and venue. The 
tests conducted at this age include eye inspection, fixation, red reflex testing, eye motility, 
Hirschberg test, retinal examination, pursuit movements, pupillary reflexes, cover test, 
alternating cover test and colour vision. Children are referred for further diagnostic 
examination after one abnormal test result. Decisions about repeat screening or referral for 
diagnostic testing in those with inconclusive results or poor cooperation is at the discretion 
of the doctor.  
5.4 Vision screening - 36 months to 7 years 
Children aged 36 months up to 7 years are screened by either a paediatrician or an 
ophthalmologist and sometimes a GP in a hospital, primary care unit or private clinic. Parents 
choose the paediatrician and venue. The tests conducted at this age include eye inspection, 
fixation, red reflex testing, eye motility, Hirschberg test, retinal examination, pursuit 
movements, pupillary reflexes, cover test, alternating cover test, colour vision and visual 
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acuity measurement. Only paediatric ophthalmologists, and very rarely general 
ophthalmologists will test visual acuity in 3.5 year-olds. A full eye examination will be 
performed at the same time in an ophthalmology clinic. No acuity testing is regularly 
performed elsewhere. Children are referred for further diagnostic examination after one 
abnormal test result. Decisions about repeat screening or referral for diagnostic testing in 
those with inconclusive results or poor cooperation is at the discretion of the doctor.  
In children above 3.5 years of age only a paediatric ophthalmologist will perform retinal 
examination and automated screening. Referral is necessary if they fail to pass the visual 
acuity screening or in the presence of abnormal examination (red reflex, motility, reflexes, 
cover test).  
Visual acuity is measured for the first time between 3.5 and 5 years of age using Lea Symbols, 
or HOTV. Vision screening is repeated between the ages of 5 to 6 years and then again at 7 to 
8 years, 9 years, 11 to 12 years, 14 to 15 years and 17 to 18 years using ETDRS, Snellen, Sloan, 
Lea Symbols or HOTV. Referral criteria:  
x <0.2 LogMAR in one or both eyes (<6/9.5 Snellen, 0.63 decimal)  
x 2 lines difference between the 2 eyes  
x Inability of the examiner to evaluate visual acuity.  
Visual acuity assessment is usually performed by general ophthalmologists, the majority of 
which use decimal non-log-scaled non-crowded visual acuity charts. A large proportion of 
paediatric ophthalmologists also use decimal non-log-scaled non-crowded visual acuity 
charts. 
The recommendations published in 2015 recommend logMAR testing (crowded or 
uncrowded), but ophthalmologists do not always follow these recommendations. Only LEA 
symbols or HOTV are recommended for visual screening in children 3.5 to 5 years old. ETDRS, 
Snellen, Sloan, LEA numbers or HOTV are recommended for VA testing, in older children. The 
ƚĞƐƚƵƐĞĚĚĞƉĞŶĚƐŽŶĐůŝŶŝĐŝĂŶ ?ƐĐŚŽŝĐĞĂŶĚƚŚĞĐŚŝůĚ ?ƐĂŐĞ ? 
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Table 1: Healthcare professionals who conduct vision screening in each age group  
Table 1 Paediatrician Ophthalmologist GP 
Preterm babies  9 9 × 
0 to 3 months  9 9 × 
3 to 36 months  9 9 × 
3 to 7 years  9 9 9 
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Table 2: Vision screening tests used in vision screening for each age group  
Table 2 EI Fix RR EM Hir RE PM PR CT ACT CV VA 
Preterm 
babies  
9 9 9 9 9 9 9 9 × × × × 
0 to 3 months  9 9 9 9 9 9 9 9 × × × × 
3 to 36 
months  
9 9 9 9 9 9 9 9 9 9 9 × 
3 to 7 years  9 9 9 9 9 9 9 9 9 9 9 9 
 
Key: EI: Eye inspection; Fix: Fixation; RR: Red reflex testing; EM: Eye motility; Hir: Hirschberg; RE: Retinal examination; PM: Pursuit movements; PR: Pupillary 
reflexes; CT: Cover test; ACT: Alternating cover test; CV: Colour vision; VA: Visual acuity measurement  
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Table 3: Location of vision screening for each age group  
Table 3 Hospital Child Healthcare Centre Primary Care Unit Private Clinic 
Preterm babies  9 × × 9 
0 to 3 months  × 9 9 9 
3 to 36 months  9 × 9 9 
3 to 7 years  9 × 9 9 
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6 Automated Screening 
Automated vision screening is achieved using handheld, portable devices designed to detect 
presence of refractive error from 6 months of age. It provides objective results and is used to 
detect amblyopic risk factors. This differs from other methods used to screen children for 
amblyopia which focus on detection of the actual condition and the resulting visual loss. No 
automated screening is used in Greece. 
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7 Provision for Visually Impaired  
In Greece, there are 8 schools for blind or severely visually impaired children. The total 
number of children that attend these 8 schools is 124. The costs per child for these schools is 
not known. It is not known if there is special support for visually impaired children who attend 
regular mainstream primary school.  
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8 Knowledge of existing screening programme 
8.1 Prevalence/Diagnosis  
No data available.  
8.2 Coverage 
No data available.  
8.3 Screening evaluation 
No data available.  
8.4 Treatment success 
Only ophthalmologists prescribe glasses for children aged under 7 years. Other treatment 
options are decided upon by the ophthalmologist but may include patching and cataract 
surgery. It is not known if all eligible children are treated. No further data is available.   
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9 Costs of vision screening in children 
9.1 Cost of vision screening  
No data available.  
9.2 Cost of treatment for amblyopia 
No data available.  
9.3 Cost of Treatment for strabismus  
 No data available.  
9.4 Cost of treatment for cataract 
No data available.  
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